Chronic Intranasal Treatment with an Anti-Aβ30-42 scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

Open Access

Peer-reviewed

Research Article

Chronic Intranasal Treatment with an Anti-Aβ_30-42 scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

Susann Cattepoel ,

* E-mail: nitsch@bli.uzh.ch

Affiliation Division of Psychiatry Research, University of Zurich, Zurich, Switzerland
⨯
Michael Hanenberg,

Affiliation Division of Psychiatry Research, University of Zurich, Zurich, Switzerland
⨯
Luka Kulic,

Affiliation Division of Psychiatry Research, University of Zurich, Zurich, Switzerland
⨯
Roger M. Nitsch

Affiliation Division of Psychiatry Research, University of Zurich, Zurich, Switzerland
⨯

Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Antibody therapy
Is the Subject Area "Antibody therapy" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Neuronal morphology
Is the Subject Area "Neuronal morphology" applicable to this article?

Thanks for your feedback.
Alzheimer's disease
Is the Subject Area "Alzheimer's disease" applicable to this article?

Thanks for your feedback.
Amyloid plaques
Is the Subject Area "Amyloid plaques" applicable to this article?

Thanks for your feedback.
Binding analysis
Is the Subject Area "Binding analysis" applicable to this article?

Thanks for your feedback.